Inj. cetirizine hcl 0.5mg
Products billed under this code include Quzyttir.
Payment limit per 0.5 MG, by effective quarter, 4Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Quzyttir.
Payment limit per 0.5 MG, by effective quarter, 4Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Quzyttir | TerSera Therapeutics LLC | 70720-0100-10 | 20 | $341.46 |
| Quzyttir | TerSera Therapeutics LLC | 70720-0100-25 | 500 | $8,536.50 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $17.073 | −$0.083 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted September 17, 2026 |
| 3Q26 | $17.156 | +$0.234 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted September 15, 2026 |
| 2Q26 | $16.922 | −$0.17 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted September 15, 2026 |
| 1Q26 | $17.092 | +$0.577 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted September 15, 2026 |
| 4Q25 | $16.515 | +$0.118 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted September 8, 2026 |
| 3Q25 | $16.397 | +$0.774 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted March 10, 2026 |
| 2Q25 | $15.623 | −$0.107 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted March 10, 2026 |
| 1Q25 | $15.73 | +$0.856 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted December 19, 2025 |
| 4Q24 | $14.874 | −$0.081 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 11, 2025 |
| 3Q24 | $14.955 | −$0.016 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 11, 2025 |
| 2Q24 | $14.971 | −$0.102 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted March 11, 2025 |
| 1Q24 | $15.073 | −$0.105 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted December 19, 2024 |
| 4Q23 | $15.178 | +$0.113 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted October 10, 2024 |
| 3Q23 | $15.065 | −$0.032 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 5, 2024 |
| 2Q23 | $15.097 | −$0.007 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted February 23, 2024 |
| 1Q23 | $15.104 | +$0.023 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted December 6, 2023 |
| 4Q22 | $15.081 | −$0.007 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 22, 2023 |
| 3Q22 | $15.088 | −$0.017 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 9, 2023 |
| 2Q22 | $15.105 | −$0.182 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted December 14, 2022 |
| 1Q22 | $15.287 | −$0.095 | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 8, 2022 |
| 4Q21 | $15.382 | – | 0.5 MG | Inj. cetirizine hcl 0.5mg | v1, posted June 2, 2022 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.